Cetera Investment Advisers
NVAX icon

Cetera Investment Advisers’s Novavax NVAX Stock Holding History

Cetera Investment Advisers’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,804
Closed -$414K – 3856
2024
Q3 		$414K Buy
+32,804
New +$424K ﹤0.01% 2808
2021
Q4 		– Sell
-1,718
Closed -$356K – 1911
2021
Q3 		$356K Buy
1,718
+333
+24% +$73.4K 0.01% 1323
2021
Q2 		$294K Sell
1,385
-670
-33% -$123K ﹤0.01% 1428
2021
Q1 		$373K Buy
+2,055
New +$410K 0.01% 1138
2020
Q4 		– Sell
-2,583
Closed -$280K – 1564
2020
Q3 		$280K Buy
+2,583
New +$315K 0.02% 521

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Cetera Investment Advisers's NVAX Position: Q4 2024 in Review

Cetera Investment Advisers sold out of Novavax (NVAX) in Q4 2024, closing a stake of 32,804 shares — an estimated $414K sold.

Cetera Investment Advisers first reported a position in NVAX in Q3 2020 and held it in 5 quarters. The position peaked at $414K in Q3 2024. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Cetera Investment Advisers reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 32,804 Novavax shares in Q4 2024, an estimated $414K.
  • Cetera Investment Advisers first reported a position in Novavax in Q3 2020 and held it in 5 quarters.
  • Cetera Investment Advisers's Novavax position peaked at $414K in Q3 2024.
  • 234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Cetera Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.